摘要
目的探讨早期目标导向治疗(EGDT)在治疗感染性休克时对患者心功能和预后的影响。方法 48例感染性休克患者分为试验组(S组,n=28)和对照组(C组,n=20)。试验组在感染性休克诊断明确入组后即开始EGDT;对照组则进行常规治疗,观察两组患者的临床症状改善情况,并分别测定液体复苏前(T0)及治疗后24 h(T1)、48 h(T2)及72 h(T3)血肌钙蛋白(IcTnI)、N末端B型利钠肽原(NT-proBNP)水平,以及液体复苏前(T0)及72 h(T3)后APACHEⅡ评分,计算住ICU时间以及28 d病死率。结果 S组患者T1、T2、T3时点的血cTn I和NT-proBNP水平显著低于对照组,差异有统计学意义(P<0.05);S组患者72 h时的APACHEⅡ评分以及住ICU时间较对照组明显降低(P<0.05);而两组患者28 d病死率差异无统计学意义(P>0.05)。结论 EGDT方案可以降低感染性休克患者血cTnI和NT-proBNP水平,对心肌损伤有保护作用,并缩短住ICU的时间。
Objective To investigate the effect of early goal- directed therapy ( EGDT ) on heart function and prognosis in the pa- tients with septic shock. Methods Forty-eight patients with septic shock were randomly divided into two groups. Patients in study group (group S, n=28 ) were treated with EGDT program, and control group (group C, n=20)with standard fluid resuscitation therapy. The concentra- tion of cardiac troponin I ( cTnI ) and N-terminal pro brain natriuretic peptide(NT-proBNP)in serum, and APACHEII score of all the patients were determined and recorded on the 0 h ( the time before initiation of treatment) and the 24 h, 48 h, and 72 h after the resuscitation. More- over, the days in ICU and the .28-day ratio were calculated in this research. Results The level of cTnI and NT-proBNP was higher in pa- tients with septic shock than that in the normal patients, and there was no difference between group S and C. After treatment, the level of cTnI and NT-proBNP in group S was decreased more obviously than that in group C at 24 h, 48 h, and 72 h(P〈 0.05) . APACHEII score and the days in ICU were decreased more significantly in group S than those in group C after the resuscitation(P〈 0.05) . There was no difference in the 28-day ratio between two groups (P〉0.05). Conclusion The treatment of EGDT program could protect myoeardiac muscle, ameliorate heart function, and shorten the days in ICU for patients with septic shock.
出处
《安徽医学》
2013年第3期274-276,共3页
Anhui Medical Journal